Welcome to...The UCLA Endocrine Surgical Unit
 

Schedule an Appointment
Endocrine Home
About Us
Our Expert Team
Our Services
First Visit for Patients
Patient Education
Scar Gallery
For Referring Physicians
Distance Surgery Program
International Patients
Insurance Questions
Map-Directions-Parking
Contact Us
Patient Experiences
Endocrine Resources
Site Map

UCLA Health System


Schedule an Appointment


Endocrine News Feeds

Worldwide News: View Endocrine News | View Parathyroid News


Sat, 25 Oct 2014 07:04:41 GMT
• Resveratrol boosts spinal bone density in men with metabolic syndrome - ProHealth

ProHealth

Resveratrol boosts spinal bone density in men with metabolic syndrome
ProHealth
Press Release: Endocrine Society, October 16, 2014. Resveratrol, a natural compound found in red wine and grapes, increased spinal bone density in men with metabolic syndrome and could hold promise as a treatment for osteoporosis, according to a new ...


Fri, 24 Oct 2014 20:30:24 GMT
• Metastatic Breast Cancer Therapy: Tried and True to What's New - MedPage Today

MedPage Today

Metastatic Breast Cancer Therapy: Tried and True to What's New
MedPage Today
For patients with metastatic HR-positive disease, endocrine therapy is my initial approach. It has proven efficacy and minimal toxicity. I consider this in patients with small-volume disease, asymptomatic visceral disease, or bone-only disease. I try to use ...

and more »

Fri, 24 Oct 2014 14:09:09 GMT
• Growers urged to respond to consultation on endocrine disruption - Farmers Guardian

Growers urged to respond to consultation on endocrine disruption
Farmers Guardian
The recently-announced European Commission public consultation is seeking views on how to regulate chemicals in the environment in terms of their ability to affect the endocrine system, which produces, stores and releases hormones in the body.

and more »

Fri, 24 Oct 2014 12:21:38 GMT
• NPS Pharma will have to wait another three months for an FDA OK - FierceBiotech

FierceBiotech

NPS Pharma will have to wait another three months for an FDA OK
FierceBiotech
The agency has extended its review by three months, NPS said, time it will spend reviewing data on the company's Natpara, a treatment for the rare endocrine disorder hypoparathyroidism. The agency asked NPS to submit a requisite plan for evaluating the ...

and more »

Fri, 24 Oct 2014 10:24:34 GMT
• In the news - Chemical Watch (subscription)

In the news
Chemical Watch (subscription)
Different options for the criteria for identifying endocrine-disrupting chemicals (EDCs) were issued for consultation by the European Commission (29 September). The consultation aims to collect information for an impact assessment on the different criteria and ...

and more »


Worldwide "Endocrine" News Courtesy of Google News